Left ventricular dyssynchrony
|
disease |
|
Disease or Syndrome
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Epithelial tumor of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
BREAST CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
11
|
24
|
0.100 |
None |
|
0 |
1
|
|
|
Medullary carcinoma of breast
|
disease |
|
Neoplastic Process
|
15
|
2
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Psychoses, Substance-Induced
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
17
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Psychoses, Drug
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
23
|
1
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Anovulation
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
32
|
8
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Spots on skin
|
phenotype |
Skin and Connective Tissue Diseases
|
Sign or Symptom
|
43
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Chocolate cyst of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
50
|
4
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Borderline ovarian tumour
|
disease |
|
Neoplastic Process
|
54
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Anovulatory (finding)
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
55
|
8
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Disseminated neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
56
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Idiopathic osteoarthritis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
63
|
12
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Generalized osteoarthritis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
63
|
10
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Female Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
71
|
15
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2013 |
Malignant neoplasm of female breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
71
|
15
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2013 |
Immunoglobulin G4-Related Disease
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
80
|
2
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
GRN-related frontotemporal dementia
|
disease |
Nutritional and Metabolic Diseases; Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
112
|
20
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Carcinoma, Granular Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
116
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Carcinoma, Cribriform
|
disease |
Neoplasms
|
Neoplastic Process
|
117
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Condition, Preneoplastic
|
disease |
Neoplasms
|
Neoplastic Process
|
122
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Adenocarcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
123
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Non-arthropod borne lymphocytic choriomeningitis
|
disease |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
133
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adenocarcinoma, Tubular
|
disease |
Neoplasms
|
Neoplastic Process
|
133
|
3
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Adenocarcinoma, Oxyphilic
|
disease |
Neoplasms
|
Neoplastic Process
|
135
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |